SYN0240576

SynDRA canonical compound SYN0240576 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	MMP1 \| MMP13 \| MMP2 \| MMP3 \| MMP9
Mechanism of action	matrix metalloprotease inhibitor

Cross-references

PubChem CID: 9907286
ChEMBL: CHEMBL323612

Synonyms

RefChem:446838
CP 471474
CP 471,474
UNII-96U47H947L
MFCD16618408
C16H17FN2O5S
orb1704599
SCHEMBL4652358
HMS3262O11
KIA75545
Tox21_500715
BDBM50148231
AKOS024457796
CCG-222019
CS-W011801
EBC-497092
HY-W011085
NCGC00261400-01
DA-72371
MS-33197
E98884
T22685
CP-471474, >=98% (HPLC)
cp-471474

Look up SYN0240576 in the interactive SynDRA portal →